SEC Form D · Amendment · filed February 24, 2025
IVIEW Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Bo Liang · Cranbury, NJExec · DirectorWei Wang · Cranbury, NJExec · DirectorJingjie Li · Cranbury, NJDirectorBin T. He · Cranbury, NJDirectorHouman Hemmati · Cranbury, NJExec · DirectorQi Zhu · Cranbury, NJDirectorXiaolu T. Sun · Cranbury, NJDirectorCarey Dillen · Vancouver, British Columbia, CanadaExec · DirectorJingjie Li · Cranbury, NJDirectorShafin Tejani · Vancouver, British Columbia, CanadaDirectorSheri Rempel · Vancouver, British Columbia, CanadaDirectorMatthew Bailey · Vancouver, British Columbia, CanadaDirectorKatrina Palanca · Vancouver, British Columbia, CanadaExec · DirectorHouman Hemmati · Cranbury, NJExec · DirectorGary S. Crittenden · SALT LAKE CITY, UTExec · DirectorJoseph S. Bonner · SALT LAKE CITY, UTExec · DirectorDiane S. Olmstead · SALT LAKE CITY, UTDirectorSpencer S. Kirk · SALT LAKE CITY, UTDirectorMichael S. Rainen · Englewood, CODirectorEbru Davidson · Sydney, Channel IslandsDirectorBryce Carmine · Sydney, Channel IslandsExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗